2020
15 April, 2020
FluoGuide A/S agrees on free-of-charge underwriting commitments regarding the exercise of warrants of series TO 1
FluoGuide issued units in its IPO in 2019. Each unit consisted of three shares and one free warrant TO 1. During the exercise period...
8 April, 2020
Ordinary General Meeting
The board of directors hereby convenes an ordinary general meeting of FluoGuide A/S, CVR no. 39 29 64 38, (the ”Company”)...
24 March, 2020
FluoGuide is shortlisted for EU grant (corrected version)
The European Commission has shortlisted over 100 game-changing ideas from across Europe with high chance of being granted EIC support...
24 March, 2020
FluoGuide is shortlisted for EU grant
The European Commission has shortlisted over 100 game-changing ideas from across Europe with high chance of being granted EIC support...
The Company’s share capital has, in connection with the registration of the directed share issue, increased to DKK 945,526.80...
28 February, 2020
Year-End Report 2019
Morten Albrechtsen, CEO of FluoGuide, comments: “I would like to thank all shareholders – new and from the IPO for the...
17 February, 2020
Communiqué from extraordinary general meeting in FluoGuide A/S
Item 1: Authorisation to the board of directors to increase the share capital at market price or at a rate discounted to the market...
31 January, 2020
Extraordinary General Meeting
The board of directors hereby convenes an extraordinary general meeting of FluoGuide A/S, CVR no. 39 29 64 38, (the ”Company”)...
29 January, 2020
FluoGuide proposes directed share issue to strengthen its ownership and shorten the time to market for FG001
FluoGuide provides solutions for maximizing surgical outcome through intelligent targeting. FluoGuide’s first product, FG001...
